María Paz Ocaranza Jeraldino

Title: Innovations of María Paz Ocaranza Jeraldino

Introduction

María Paz Ocaranza Jeraldino is a prominent inventor based in Santiago, Chile. She has made significant contributions to the field of medicine, particularly in the development of treatments for hypertension and cardiovascular diseases. With a total of 2 patents, her work is recognized for its innovative approach to addressing critical health issues.

Latest Patents

Her latest patents include the use of the angiotensin-(1-9) peptide or its derivatives for preparing medicaments that are useful in preventing, reverting, inhibiting, and/or reducing hypertension and inducing vasodilation. This invention focuses on the application of a vector that overexpresses the ACE2 enzyme, which is crucial for elevating the concentration of angiotensin-(1-9) in the blood and tissues. The vector can be an adenovirus, retrovirus, lentivirus, or adeno-associated virus containing the gene encoding for ACE2. Additionally, her pharmaceutical compositions are designed to treat cardiovascular, pulmonary, cerebral, and renal remodeling.

Career Highlights

Ocaranza has worked with prestigious institutions such as Universidad de Chile and Pontificia Universidad Católica de Chile. Her research has led to advancements in the understanding and treatment of cardiovascular conditions, showcasing her dedication to improving public health.

Collaborations

Some of her notable collaborators include Jorge Emilio Jalil Milad and Sergio Alejandro Lavandero González. Their combined expertise has contributed to the success of her innovative projects.

Conclusion

María Paz Ocaranza Jeraldino stands out as a leading inventor in the medical field, with her patents paving the way for new treatments for hypertension and related conditions. Her work exemplifies the impact of innovation in healthcare.